Dr. Jeffrey W. Sherman, MD, FACP, Infectious Disease Specialist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Jeffrey W. Sherman, MD, FACP

Infectious Disease Specialist | Infectious Disease

1 Horizon Way Deerield Illinois, 60015

About

Jeffrey (Jeff) Sherman, MD, FACP, is a clinical research specialist who was trained in internal medicine and infectious diseases. He is the Chief Medical Officer Emeritus of Horizon Therapeutics now Amgen (Rare Disease) located in Deerfield, Illinois. Dr. Sherman specializes in new medicine development particularly in rare diseases that are devastating.

Education and Training

Lake Forest College bachelor's degree in biology 0

Rosalind Franklin University of Medicine and Science/The Chicago Medical School MD 0

Chicago Medical School at Rosalind Franklin University of Medicine & Science 1981

Board Certification

Infectious Disease (Internal Medicine)

American Board of Internal Medicine (ABIM)

Provider Details

Male English

Areas of expertise and specialization

Clinical Research

Faculty Titles & Positions

  • Chief Medical Officer Emeritus at Horizon Therapeutics now Amgen (Rare Disease) -
  • Chief Resident Northwestern University -
  • FDA Clinical Trial Transformation Initiative (CTTI) Steering Committee Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP -

Awards

  • PharmaVoice 100 2020 PharmaVoice 

Professional Memberships

  • Drug Information Association (DIA) Inagural Fellow  
  • American College of Physicians (FACP)  

Fellowships

  • University of California-San Francisco (UCSF) infectious diseases 

Charities and Philanthropic Endeavors

  • Center for Healthcare Innovation (CHI)
  • Cures Within Reach
  • Erie Family Health Foundation
  • The Center for Information and Study on Clinical Research Participation (CISCRP)
  • National Organization for Rare Diseases (NORD) and the European Organization for Rare Diseases (EURORDIS)

Internships

  • Northwestern University McGaw Medical Center - Internal Medicine

Fellowships

  • University of California San Francisco (UCSF) - Infectious Diseases

Professional Society Memberships

  • AABB, AACE, AACR, AAN, AANS, AAO, AAPS, AAPOS, ACCP, ACG, ACP, ACR, ACRP, AGA, AMA, AMCP, APCR, ARVO, ASCO, ASCPT, ASH, ASM, ASN, ASPO, ASTCT, ASTRO, ATA, CIS, CNS, EACR, EANO, ENDO, ESCIMD, ESMO, IASP, ICIS, IDSA, IPHA, ISoP, NANOS, NFID, RCP, RNS, SIOP, SITC, SMID, SNO, SSIEM, WIO

Articles and Publications

  • New England Journal of Medicine (NEJM), 382:4, January 23, 2020, 341-352, "Teprotumumab (TEPEZZA) for the Treatment of Active Thyroid Eye Disease (TED)"

What do you attribute your success to?

  • Patient Focus

Areas of research

  • Rare Diseases

Awards

  • Drug Information Association (DIA) Outstanding Service Award

Teaching and speaking

  • Stanford MTRAM

Hobbies / Sports

  • Travel

Areas of research

Rare Diseases

Dr. Jeffrey W. Sherman, MD, FACP's Practice location

Horizon Therapeutics Now Amgen (Rare Disease)

1 Horizon Way -
Deerield, Illinois 60015
Get Direction
New patients: 847-383-3011

Dr. Jeffrey W. Sherman, MD, FACP's reviews

(0)
Write Review

Media Releases

Get to know Clinical Research Specialist Dr. Jeffrey W. Sherman.

An experienced clinical research and pharmaceutical development specialist, Dr. Sherman was the Chief Medical Officer now Emeritus at Horizon Therapeutics now Amgen (Rare Disease) located in Deerfield, Illinois. 

Educated in the United States, he earned his bachelor’s degree in biology from Lake Forest College before embarking on his medical voyage at the Rosalind Franklin University of Medicine and Science/The Chicago Medical School, where he obtained his medical degree. 

Following this, Dr. Sherman undertook rigorous training, completing an internship and residency in internal medicine at Northwestern University, where his exceptional skills led him to serve as Chief Resident. Further enhancing his expertise, he pursued fellowship training in infectious diseases at the University of California-San Francisco (UCSF), as well as contributing to research endeavors as a research associate at the Howard Hughes Medical Institute at UCSF, specializing in allergy and immunology.

Recognized as a Fellow of the American College of Physicians (FACP), the doctor is board-certified in internal medicine and infectious diseases by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

With over 35 years of invaluable experience in the field, he has left an indelible mark on the industry landscape, having traversed through various prominent roles in renowned pharmaceutical companies such as IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, and Squibb/Bristol-Myers Squibb. His influence spans across various advisory boards and committees, exemplified by his past board of directors chair of the Drug Information Association (DIA) and membership on the Board of Directors. Noteworthy is his pivotal role in steering the DIA Annual Meeting as chairperson and his recognition with an Outstanding Service Award, further solidifying his reputation as an exemplary leader in the field. 

Having served as a liaison to the FDA Clinical Trial Transformation Initiative (CTTI) Steering Committee and on the Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP), Dr. Sherman has actively contributedHa to shaping policy and advancing clinical research methodologies.

Furthermore, his philanthropic endeavors underscore his commitment to addressing rare diseases, evident through his involvement with the Global Genes Medical and Scientific Advisory Board and his engagement with the National Organization for Rare Diseases (NORD) and the European Organization for Rare Diseases (EURORDIS).

Recommended Articles

  • What Is MRSA Infection?

    What is MRSA Infection ?MRSA (methicillin-resistant Staphylococcus aureus) infection is a bacterial infection caused by Staphylococcus aureus that has become resistant to many of the antibiotics commonly used for the treatment of a staphylococcus infection (and is consequently called "the...

  • The Three Stages of Lyme Disease

    The problem with Lyme disease is that it is difficult to treat because the organism responsible for the disease hides from your immune system. Lyme disease goes through three stages, and in each stage, they produce different signs and symptoms. The three stages of Lyme disease are:...

  • Eight Facts About Lyme Disease

    Lyme disease is a bacterial infection caused by Borrelia burgdorferi. It is common in North America and Europe. Many people do not know much about this disease and its harmful effects if left untreated. Here are some facts that you need to know about Lyme disease.The majority of the patients with...

  • What Are the Signs and Symptoms of AIDS?

    Acquired immunodeficiency syndrome, or AIDS, is a serious secondary immunodeficiency disorder. AIDS is caused by human immunodeficiency virus (HIV). There is progressive destruction of cell-mediated (T cell) immunity. Also, both conditions are characterized by subsequent effects on humoral immunity...

  • Foodborne Diseases Commonly Occur With Imported Foods

    According to the CDC, imported foods from different countries are causing more outbreaks of foodborne diseases. “Among the different foods imported from other countries, fish and spices, particularly pepper, are the culprits," says Hannah Gould, PhD, said in a report presented at the International...

  • What Is Cholera: Get the Facts

    Cholera is a very dangerous disease, which is caused by the bacterium called Vibrio cholerae. Someone infected with cholera experiences painless and watery diarrhea. Due to continuous diarrhea, one is likely to develop dehydration which can result in death. Many people who get cholera happen to...

Nearby Providers